Please ensure Javascript is enabled for purposes of website accessibility
top of page
N=1 Collaborative

Individualized ASO therapy for rare diseases

Updated: Aug 11, 2023

Published: February 28, 2023


Annemieke Aartsma-Rus is a Professor of Translational Genetics at the Leiden University Medical Center. She was one of the pioneers of antisense oligonucleotide (ASO)-mediated exon skipping therapy for Duchenne muscular dystrophy (DMD). Her work focuses on the personalized approach to delivering exon skipping therapy for patients with rare genetic diseases within the setting of the Dutch Center for RNA Therapeutics, which she co-founded in 2020 and is on the Board of Directors. Currently, four exon skipping drugs have been approved by the US Food and Drug Administration for DMD, three of which are based on the IP generated by Aartsma-Rus’ institute. She is also involved in patient education in collaboration with the Duchenne Patient Academy and the European Organisation for Rare Diseases (Eurordis). In this Q&A, we ask Prof. Aartsma-Rus a series of questions on the latest developments in therapies for rare diseases and how best to overcome some of the existing challenges with this endeavour.


ree




Individualized ASO therapy for rare diseases. Commun Med3, 27 (2023).

https://doi.org/10.1038/s43856-023-00255-3


ree

We envision a future where individualized medicine centers around the world routinely offer patients customized treatments targeting their condition’s underlying genetic cause.




info@n1collaborative.org

 
 
 

1 Comment


Azmi
Azmi
Sep 30

My husband was diagnosed with Creutzfeldt-Jakob Disease (CJD) four years ago. For over two years, we relied on prescription medications and therapies, but unfortunately, his symptoms continued to worsen. His memory, coordination, and overall strength declined, and everyday life became increasingly difficult.Last year, out of desperation and hope, we decided to try an herbal treatment program from NaturePath Herbal Clinic. Honestly, we were skeptical at first, but within a few months of starting the treatment, we began to notice real changes. His alertness improved, his movements became steadier, and he regained a surprising amount of energy and clarity.Incredibly, he also regained much of his independence and confidence. It’s been a life-changing experience he feels more like himself again, better than…

Like

Join Our Community List

Relationship Required
Area(s) of Interest Required

Thanks for submitting!

N=1 Collaborative

Contact Us

501c3 Nonprofit Organization

EIN: 88-2591503

©2024 by N=1 Collaborative

Crafted By: Finfrock Marketing

bottom of page